Court
Tamir Capital is invested in Proneuron, which successfully sued Teva for abuse of a license for its product.
Hi, what are you looking for?
Jewish Business News
All posts tagged "Teva Pharmaceutical Industries"
Business
Board concludes that approach grossly undervalues Mylan, includes Teva stock, and would expose Mylan to a problematic culture and leadership with poor record of...
Business
Teva CEO Erez Vigodman bypasses Mylan's board and appeals directly to its shareholders.
Business
Generic drugmaker Mylan (MYL) said on Friday it would take its $31 billion offer for Perrigo Co Plc directly to shareholders, in what is...
Business
Bloomberg reports that Teva is working with Barclays Bank on a takeover bid for Mylan.
Blogs
In the 12th Apr 2015 week’s edition of Israel’s good news, the highlights include: Two major Israeli scientific breakthroughs may lead to new cancer...
Money
Shares of Teva Pharmaceutical Industries traded up 0.87% on Monday, hitting $62.52.
Business
Teva’s American Depositary Receipts rose 2.2 percent to $63.31, giving it a market value of just under $54 billion.
Business
Teva is selling four targeted oncology development programs to Ignyta for 6% of the biotech company.
Business
G&W Pharmaceuticals will have the right to produce and sell some of Teva's products